◆英語タイトル:Octapharma AG - Strategic SWOT Analysis Review
◆商品コード:DATA904C0599
◆発行会社(調査会社):
GlobalData
◆発行日:2018年7月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Octapharma AG – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights
Octapharma AG (Octapharma) is a human protein manufacturer that focuses on developing and producing human proteins from human plasma and cell lines. The company treats patients worldwide with products across haematology (coagulation disorders), immunotherapy (immune disorders) and critical care therapeutic areas. It sources majority of plasma from company-owned donation centers. Octapharma owns plasma donation centers in the USA and in Germany, and owns six state-of-the-art production facilities in Austria, Germany, France, Mexico and Sweden. The company’s production plants carry out plasma fractionation and purification, pharmaceutical production, research and development, product labelling, packaging, storage and distribution. Octapharma is headquartered in Lachen, Switzerland.
Octapharma AG Key Recent Developments
May 28,2018: Octapharma present new data on the benefits of Nuwiq in patients with haemophilia A at the World Federation of Hemophilia 2018 World Congress
Mar 01,2018: Octapharma Group publishes 2017 annual results reporting revenue of €1.72 billion and operating income of €349 million
Mar 01,2017: Octapharma Group Publishes 2016 Annual Results Reporting Revenue of €1.6 Billion and Operating Income of €383 Million
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Octapharma AG – Key Facts 5
Octapharma AG – Key Employees 6
Octapharma AG – Major Products and Services 7
Octapharma AG – History 9
Octapharma AG – Company Statement 11
Octapharma AG – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 15
Company Overview 15
Octapharma AG – Business Description 16
Octapharma AG – Corporate Strategy 17
Octapharma AG – SWOT Analysis 18
SWOT Analysis – Overview 18
Octapharma AG – Strengths 18
Octapharma AG – Weaknesses 19
Octapharma AG – Opportunities 20
Octapharma AG – Threats 21
Octapharma AG – Key Competitors 22
Section 3 – Company’s Lifesciences Financial Deals and Alliances 23
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 23
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 24
Octapharma AG, Recent Deals Summary 25
Section 4 – Company’s Recent Developments 26
May 28, 2018: Octapharma present new data on the benefits of Nuwiq in patients with haemophilia A at the World Federation of Hemophilia 2018 World Congress 26
Mar 01, 2018: Octapharma Group publishes 2017 annual results reporting revenue of €1.72 billion and operating income of €349 million 27
Mar 01, 2017: Octapharma Group Publishes 2016 Annual Results Reporting Revenue of €1.6 Billion and Operating Income of €383 Million 28
Section 5 – Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Tables
Octapharma AG, Key Facts 5
Octapharma AG, Key Employees 6
Octapharma AG, Major Products and Services 7
Octapharma AG, History 9
Octapharma AG, Other Locations 12
Octapharma AG, Subsidiaries 12
Octapharma AG, Key Competitors 22
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 23
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 24
Octapharma AG, Recent Deals Summary 25
List of Figures
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 23
Octapharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 24